Medical News

RSS

New resuscitation program shows major improvement in patient outcome after cardiac arrest

ZOLL Medical Corporation announced today that in a “Best of the Best” presentation at the American Heart Association Resuscitation Science Symposium in Orlando Florida, Daniel P. Davis, M.D., presented research from the University of California Resuscitation Research Center that shows a major improvement in patient outcome after cardiac arrest.

17 Nov 2009

Incidence of stroke related to coronary angioplasty remain steady over a 15-year period: Mayo Clinic study

Results of a Mayo Clinic study show the incidence of stroke or mini-stroke related to a coronary angioplasty (http://www.mayoclinic.org/heart-catheterization/types.html) remained steady over a 15-year period. Researchers say this is good news because physicians now are performing the artery-opening procedure on older patients who are sicker and need more complicated treatment.

17 Nov 2009

Genentech submits sBLAs to the FDA for Avastin

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.

17 Nov 2009

Study establishes link between smoking and Amyotrophic Lateral Sclerosis

While previous studies have indicated a "probable" connection between smoking and ALS, a new study published in the Nov. 17, 2009 issue of Neurology-, the medical journal of the American Academy of Neurology, states that smoking may now be considered an "established" risk factor for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease.

17 Nov 2009

FDA provides feedback on the pending NDA for EXALGO tablets

CombinatoRx, Incorporated and Neuromed Pharmaceuticals Inc., a privately-held biopharmaceutical company, today announced that on November 13, 2009, representatives of Neuromed discussed the pending New Drug Application (NDA) for the product candidate EXALGOTM (hydromorphone HCl extended release) tablets, seeking FDA approval for the management of moderate to severe pain in opioid tolerant patients requiring continuous, around-the-clock opioid analgesia for an extended period of time, with staff from the United States Food and Drug Administration (FDA).

17 Nov 2009

ThromboGenics and BioInvent International present phase I results of novel anti-cancer monoclonal antibody

ThromboGenics NV and BioInvent International AB today announced positive results from a Phase I trial of their novel anti-cancer monoclonal antibody TB-403 in patients with advanced solid tumours. The results were presented at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston, U.S. TB-403 was well tolerated with no reported dose limiting toxicity. These positive data support progression of TB-403 and further development.

17 Nov 2009

Lack of sleep can lead to devastating errors, says new study

Sleep deprivation adversely affects automatic, accurate responses and can lead to potentially devastating errors, a finding of particular concern among firefighters, police officers, soldiers and others who work in a sleep-deprived state, University of Texas at Austin researchers say.

17 Nov 2009

Play video games to prevent or improve obesity and lifestyle-related disease

Active Wii sports- video games and some Wii fit- activities may increase adults' energy expenditure as much as moderately intense exercise, according to research presented at the American Heart Association's Scientific Sessions 2009.

17 Nov 2009

Phase II clinical study to evaluate Nanocort commenced

Galapagos NV announced today that it has started a Phase II clinical study to evaluate Nanocort's effectiveness in treating flares in multiple sclerosis (MS). Nanocort combines less frequent treatment with lower dosage and potentially more effective delivery than other MS flare treatments.

17 Nov 2009

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

For the second consecutive year, Colorado received a “D” on the Premature Birth Report Card issued by the March of Dimes. However, the state did show improvement in two key areas that affect prematurity, including the rate of smoking for childbearing-age women.

17 Nov 2009

Remedent net sales decreases to $1.8 million in fiscal second quarter ended September 30, 2009

Remedent, Inc., an international company specializing in the research, development, and manufacturing of oral care and cosmetic dentistry products, reported results for the fiscal second quarter ended September 30, 2009 (in U.S. dollars).

17 Nov 2009

Elsevier to publish official journal of ACAAI

Elsevier is pleased to announce that beginning with Volume 104 (2010) it will assume publication of the Annals of Allergy, Asthma & Immunology, the official journal of the American College of Allergy, Asthma & Immunology (ACAAI).

17 Nov 2009

Trustmark Voluntary Benefit Solutions offers coverage for vaccines including H1N1 to its policyholders

Trustmark Voluntary Benefit Solutions, a leading provider of payroll-deducted voluntary benefits, is now covering vaccines including H1N1 (swine flu).

17 Nov 2009

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company developing products for female sexual health, including LibiGel® for the treatment of hypoactive sexual desire disorder (HSDD), applauds the efforts of Boehringer Ingelheim to develop a therapy to treat this unmet medical need.

17 Nov 2009

Program for childhood cancer survivors to quit smoking

As smokers nationwide struggle to quit the habit, St. Jude Children's Research Hospital is offering assistance to those childhood cancer survivors who need help with smoking cessation.

17 Nov 2009

Erratic heart rhythms during exercise do not pose risk to healthy, older adults

Healthy, older adults free of heart disease need not fear that bouts of rapid, irregular heartbeats brought on by vigorous exercise might increase short- or long-term risk of dying or having a heart attack, according to a report by heart experts at Johns Hopkins and the U.S. National Institute on Aging (NIA).

17 Nov 2009

Three-stage GDL policies could save lives and prevent injuries in Midwest

A new study shows that three-stage graduated driver's licensing (GDL) policies save lives and prevents injuries throughout the Midwest. The research published in the Wisconsin Medical Journal (Vol. 108, No. 8) also shows how states could save more teen lives and avoid thousands of teen motor vehicle injuries by modifying their GDL policies to include new, proven components.

17 Nov 2009

FDA's BPAC renders positive opinion on Phase III clinical trial of INTERCEPT Blood System

Cerus Corporation announced today that the FDA's Blood Products Advisory Committee (BPAC) rendered a positive opinion on the proposed hemostatic efficacy and safety endpoints for a potential U.S. Phase III clinical trial of the INTERCEPT Blood System for platelets.

17 Nov 2009

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

Roche`s RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 influenza virus has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA). The Roche kit detects RNA from the 2009 H1N1 influenza A virus and allows rapid and accurate identification of patients infected with this virus.

17 Nov 2009

New Web-based application for tracking the H1N1 flu virus across the globe

New methods of studying avian influenza strains and visually mapping their movement around the world will help scientists more quickly learn the behavior of the pandemic H1N1 flu virus, Ohio State University researchers say.

17 Nov 2009

Medical News

New resuscitation program shows major improvement in patient outcome after cardiac arrest

Incidence of stroke related to coronary angioplasty remain steady over a 15-year period: Mayo Clinic study

Genentech submits sBLAs to the FDA for Avastin

Study establishes link between smoking and Amyotrophic Lateral Sclerosis

FDA provides feedback on the pending NDA for EXALGO tablets

ThromboGenics and BioInvent International present phase I results of novel anti-cancer monoclonal antibody

Lack of sleep can lead to devastating errors, says new study

Play video games to prevent or improve obesity and lifestyle-related disease

Phase II clinical study to evaluate Nanocort commenced

Colorado receives “D” on Premature Birth Report Card for the second consecutive year

Remedent net sales decreases to $1.8 million in fiscal second quarter ended September 30, 2009

Elsevier to publish official journal of ACAAI

Trustmark Voluntary Benefit Solutions offers coverage for vaccines including H1N1 to its policyholders

BioSante Pharmaceuticals applauds Boehringer Ingelheim for developing a therapy to treat HSDD

Program for childhood cancer survivors to quit smoking

Erratic heart rhythms during exercise do not pose risk to healthy, older adults

Three-stage GDL policies could save lives and prevent injuries in Midwest

FDA's BPAC renders positive opinion on Phase III clinical trial of INTERCEPT Blood System

Roche receives EUA from FDA for its RealTime ready Influenza A/H1N1 Detection Set for the 2009 H1N1 virus

New Web-based application for tracking the H1N1 flu virus across the globe

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Latest News